ITAT: Allows Pfizer’s initial year marketing spend as economic adjustment; Excludes ‘pass through cost’ from cost-base

Jan 11, 2022

Simply Register/Sign In to access the free content across the portals!

Not subscribed yet?
Gain access to unlimited paid content by subscribing to our portals

View Subscriptions

Sign in to access the content